Results
SMS Pharma Q1 Revenue Up 6% YoY, PAT Rises 8%
SMS Pharma reported Q1FY27 revenue of ₹207 crore, up 6% YoY, with PAT increasing 8% to ₹20.20 crore.
EBITDA margin sustained at 20% despite headwinds from employee increments and elevated freight cost
